Compounds > clindamycin

clindamycin and Erysipelas

clindamycin has been researched along with Erysipelas in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Courjon, J; Demonchy, E; Klotz, C; Michelangeli, C; Roger, PM; Ruimy, R	1
Steurer, J	1
Jacobs, F; Kubiak, J; Schaller, M; Stroelin, A	1
Bacmann, D; Roller, E; Schulte, KW; Stege, H	1
Conti, E; de Lalla, F; Lazzarini, L; Tositti, G	1
Koster, JB; Kullberg, BJ; van der Meer, JW	1
Arata, J; Nohara, N; Suwaki, M; Yamamoto, Y	1

Trials

1 trial(s) available for clindamycin and Erysipelas

Article	Year
[Clindamycin vs. trimethoprim-sulfamethoxazole: equally effective in skin infections]. Praxis, 2015, Jun-03, Volume: 104, Issue:12 Topics: Abscess; Adult; Child; Clindamycin; Double-Blind Method; Emergency Service, Hospital; Erysipelas; Female; Humans; Male; Primary Health Care; Trimethoprim, Sulfamethoxazole Drug Combination; United States	2015

Other Studies

6 other study(ies) available for clindamycin and Erysipelas

Article	Year
Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:4 Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Blood Culture; Cellulitis; Clindamycin; Erysipelas; Female; France; Guideline Adherence; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2019
Recurrent erysipelas secondary to a late prosthetic femoropopliteal bypass infection. Acta dermato-venereologica, 2013, Volume: 93, Issue:1 Topics: Aged; Anti-Infective Agents; Aza Compounds; Blood Vessel Prosthesis; Clindamycin; Coated Materials, Biocompatible; Erysipelas; Femoral Artery; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillin G; Peripheral Vascular Diseases; Popliteal Artery; Prosthesis-Related Infections; Quinolines; Recurrence; Reoperation	2013
[Necrotizing erysipelas bordering on necrotizing fasciitis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:10 Topics: Aged; Anti-Bacterial Agents; Clindamycin; Diagnosis, Differential; Erysipelas; Fasciitis, Necrotizing; Humans; Male; Necrosis; Skin; Skin Transplantation	2003
Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. The Journal of infection, 2005, Volume: 51, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Blood Sedimentation; C-Reactive Protein; Cellulitis; Clindamycin; Erysipelas; Female; Humans; Italy; Length of Stay; Leukocyte Count; Male; Middle Aged; Penicillins; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome	2005
Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies. The Netherlands journal of medicine, 2007, Volume: 65, Issue:3 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clindamycin; Erysipelas; Ethylenediamines; Humans; Penicillins; Recurrence; Retrospective Studies; Treatment Failure	2007
[Clindamycin-2-phosphate in the field of dermatology (author's transl)]. The Japanese journal of antibiotics, 1977, Volume: 30, Issue:1 Topics: Adolescent; Adult; Animals; Cellulitis; Clindamycin; Erysipelas; Female; Furunculosis; Humans; Male; Middle Aged; Organophosphorus Compounds; Rats; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus	1977